FDA Inspection
Chongqing Kangle Pharmaceutical Co., LtdChongqing Kangle Pharmaceutical Co., Ltd – FDA Inspection, Jul 26, 2018
Record Details
This FDA Inspection record concerns Chongqing Kangle Pharmaceutical Co., Ltd, with an inspection on July 26, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · d6272298-6c9d-42d7-b3ad-95df1968b5f5
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1064345
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Chongqing Kangle Pharmaceutical Co., Ltd
3| Date | Classification | Office | Project area |
|---|---|---|---|
| September 5, 2025 | Not classified | Office of Inspections and Investigations | |
| January 30, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 26, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Chongqing Kangle Pharmaceutical Co., Ltd
- FDA Inspection 1286254 - 2025-09-05
- FDA Inspection 912714 - 2015-01-30
- FDA Inspection 783920 - 2012-04-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.